{"id":"W2252811454","doi":"10.1097/qai.0000000000000790","title":"Brief Report","year":2015,"lang":"en","type":"article","venue":"JAIDS Journal of Acquired Immune Deficiency Syndromes","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Cilag; GlaxoSmithKline; ViiV Healthcare; Gilead Sciences; Pfizer; Bristol-Myers Squibb","keywords":"Dolutegravir; Abacavir; Lamivudine; Emtricitabine; Efavirenz; Medicine; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy; Chronic hepatitis; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001618221,0.0002482301,0.0007819763,0.0005718302,0.00008877603,0.00004563323,0.0002352915,0.0001036976,0.00008910875],"category_scores_gemma":[0.0008873758,0.0001801672,0.000344395,0.0007570109,0.000129448,0.00032787,0.00007302401,0.000120247,0.0002309697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002406041,"about_ca_system_score_gemma":0.0007990472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001088568,"about_ca_topic_score_gemma":4.430339e-7,"domain_scores_codex":[0.9970379,0.00006290207,0.001256707,0.0002264416,0.001006997,0.0004090927],"domain_scores_gemma":[0.9978256,0.00008042291,0.0006614586,0.0004372531,0.0006528234,0.0003423943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.003064641,0.007606212,0.4851923,0.0005588303,0.004268163,0.1794304,0.01765534,0.0001640968,0.02464718,0.002047118,0.2181769,0.05718875],"study_design_scores_gemma":[0.02569609,0.006711659,0.3405913,0.001956734,0.002294933,0.4120869,0.009167519,0.0001861847,0.02393843,0.002678575,0.1730893,0.001602395],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9804972,0.005899683,0.0003334971,0.003739594,0.001217126,0.0002269403,0.000002162895,0.00008325336,0.008000545],"genre_scores_gemma":[0.9641286,0.0001807779,0.004756019,0.00006685054,0.0001073494,0.000005205176,0.00001551791,0.00004330208,0.03069645],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2326565,"threshold_uncertainty_score":0.7347007,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0341467119659951,"score_gpt":0.2919896861536674,"score_spread":0.2578429741876723,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}